Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 9;9(6):1798.
doi: 10.3390/jcm9061798.

Robotic-Assisted Simple Prostatectomy: A Systematic Review

Yakup Kordan  1 , Abdullah Erdem Canda  1 , Ersin Köseoğlu  1 , Derya Balbay  1 , M Pilar Laguna  2 , Jean de la Rosette  2   3
Affiliations
Review

Robotic-Assisted Simple Prostatectomy: A Systematic Review

Yakup Kordan et al. J Clin Med. .

Abstract

Contemporary minimally invasive surgical (MIS) treatment options of patients with male Lower Urinary Tract Symptoms (LUTS) in men with prostate glands >80 mL include Holmium Laser Enucleation Prostate (HoLEP), Thulium laser VapoEnucleation Prostate (ThuVEP), and Laparoscopic (LSP) or Robotic-Assisted Simple Prostatectomy (RASP). Implementing new laser technologies is costly, and the steep learning curve of these laser techniques limit their wide range use. This promoted the use of LSP and RASP in centers with readily established laparoscopy or robotic surgery programs. The aim of this study is to review case and comparative series of RASP. We systematically reviewed published data from 2008 to 2020 on RASP and have identified 26 non-comparative and 9 comparative case series. RASP has longer operation time but less time spent in hospital and less blood loss. The outcomes of improvements in symptom score, post-voiding residual urine (PVR), postoperative PSA decline, complications, and cost are similar when compared to open and laser enucleation techniques. These outcomes position RASP as a viable MIS treatment option for patients with male LUTS needing surgical treatment for enlarged prostates. Nevertheless, prospective, randomized controlled trials (RCTs) with multicenter and large sample size are needed to confirm the findings of this systematic review.

Keywords: benign prostate hyperplasia; miminally invasive simple prostatectomy; minimally invasive adenomectomy; robotic adenomectomy; robotic simple prostatectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA 2009 flowchart for the article selection process.
See this image and copyright information in PMC

References

    1. Elshal A.M., El-Nahas A.R., Barakat T.S., Elsaadany M.M., El-Hefnawy A.S. Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series. Arab. J. Urol. 2013;11:362–368. doi: 10.1016/j.aju.2013.06.003. - DOI - PMC - PubMed
    1. Mariano M.B., Graziottin T.M., Tefilli M.V. Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia. J. Urol. 2002;167:2528–2529. doi: 10.1016/S0022-5347(05)65025-2. - DOI - PubMed
    1. Sotelo R., Clavijo R., Carmona O., Garcia A., Banda E., Miranda M., Fagin R. Robotic simple prostatectomy. J. Urol. 2008;179:513–515. doi: 10.1016/j.juro.2007.09.065. - DOI - PubMed
    1. Meyer D., Weprin S., Zukovski E.B., Porpiglia F., Hampton L.J., Autorino R. Rationale for Robotic-assisted Simple Prostatectomy for Benign Prostatic Obstruction. Eur. Urol. Focus. 2018;4:643–647. doi: 10.1016/j.euf.2018.07.007. - DOI - PubMed
    1. Foster H.E., Barry M.J., Dahm P., Gandhi M.C., Kaplan S.A., Kohler T.S., Lerner L.B., Lightner D.J., Parsons J.K., Roehrborn C.G., et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J. Urol. 2018;200:612–619. doi: 10.1016/j.juro.2018.05.048. - DOI - PubMed